GSK plc

GSK plc EBIT per Employee

The EBIT per Employee of GSK plc (GSK.L) as of Oct 16, 2026 is 82,941.76 GBP. In the previous year, EBIT per Employee was 60,191.78 GBP — a change of 37.80% (higher).

EBIT per Employee

82,941.76GBP

YoY

37.80%

Last updated:

EBIT per Employee of GSK plc is 2025 82,941.76 GBP. EBIT per Employee of GSK plc was 2024 60,191.78 GBP. It decreases by 37.80% higher compared to the previous year.

The GSK plc EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2018
85,036.04 GBP
Jan 1, 2019
82,739.78 GBP
Jan 1, 2020
86,992.11 GBP
Jan 1, 2021
57,459.66 GBP
Jan 1, 2022
71,035.23 GBP
Jan 1, 2023
74,341.42 GBP
Jan 1, 2024
60,191.78 GBP
Jan 1, 2025
82,941.76 GBP
The GSK plc EBIT per Employee history
YEAREBIT per EmployeeYoY
82,941.76GBP+37.80%
60,191.78GBP-19.03%
74,341.42GBP+4.65%
71,035.23GBP+23.63%
57,459.66GBP-33.95%
86,992.11GBP+5.14%
82,739.78GBP-2.70%
85,036.04GBP+0.31%
84,770.27GBP+16.75%
72,608.59GBP+53.10%
47,424.15GBP-8.94%
52,080.45GBP—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

GSK plc Stock analysis

What does GSK plc do? GSK plc, listed on the London Stock Exchange under the ticker GSK.L, is a pharmaceutical company headquartered in Brentford, United Kingdom. The company, which has been publicly traded since May 22, 1972, operates within the healthcare sector, specifically in the pharmaceuticals industry. GSK employs 94,066 full-time staff, focusing on the research, development, and manufacturing of pharmaceutical medicines, vaccines, and consumer healthcare products. The company's operations are structured around two primary segments: Pharmaceuticals and Vaccines. In the Pharmaceuticals segment, GSK develops and markets medicines for a variety of conditions, including respiratory diseases, HIV and infectious diseases, immuno-inflammation, oncology, and rare diseases. The Vaccines segment provides immunization solutions for all age groups, from infants to the elderly, including pediatric, adolescent, adult, and travel vaccines. GSK's portfolio includes prescription medicines and vaccines, with a particular emphasis on respiratory and HIV-related treatments. The company's business strategy encompasses both innovative therapeutic areas and established product lines, supporting its global presence in healthcare. GSK's official website is www.gsk.com, offering further information about its products and initiatives. GSK plc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GSK plc stock

EBIT per Employee of GSK plc is 82,941.76 GBP in 2025.

EBIT per Employee of GSK plc changed from 60,191.78 GBP to 82,941.76 GBP, representing a 37.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee GSK plc since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's GBP is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's GSK plc historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — GSK plc

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — GSK plc